news
Scmp World
2026-05-29
Innovent Biologics Partners with Pfizer for $10.5 Billion Cancer Drug Development
Chinese biopharmaceutical company Innovent Biologics has signed a major collaboration deal with Pfizer to jointly develop 12 cancer treatments, potentially worth up to $10.5 billion.